nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—hair follicle—melanoma	0.00954	0.14	CbGeAlD
Fludarabine—Adenosine triphosphate—APAF1—melanoma	0.00849	0.758	CrCbGaD
Fludarabine—SLC28A3—mammalian vulva—melanoma	0.00677	0.0991	CbGeAlD
Fludarabine—POLA1—retina—melanoma	0.00594	0.0869	CbGeAlD
Fludarabine—RRM1—eye—melanoma	0.00476	0.0696	CbGeAlD
Fludarabine—POLA1—mammalian vulva—melanoma	0.00476	0.0696	CbGeAlD
Fludarabine—RRM1—retina—melanoma	0.00472	0.069	CbGeAlD
Fludarabine—RRM1—skin of body—melanoma	0.00414	0.0606	CbGeAlD
Fludarabine—RRM1—mammalian vulva—melanoma	0.00378	0.0552	CbGeAlD
Fludarabine—DCK—retina—melanoma	0.00366	0.0536	CbGeAlD
Fludarabine—SLC29A1—mammalian vulva—melanoma	0.00307	0.0449	CbGeAlD
Fludarabine—DCK—mammalian vulva—melanoma	0.00293	0.0429	CbGeAlD
Fludarabine—RRM1—head—melanoma	0.0027	0.0395	CbGeAlD
Fludarabine—POLA1—lymph node—melanoma	0.00238	0.0349	CbGeAlD
Fludarabine—Adenosine triphosphate—AKT1—melanoma	0.00231	0.206	CrCbGaD
Fludarabine—SLC29A1—head—melanoma	0.0022	0.0321	CbGeAlD
Fludarabine—DCK—head—melanoma	0.0021	0.0307	CbGeAlD
Fludarabine—RRM1—lymph node—melanoma	0.00189	0.0277	CbGeAlD
Fludarabine—Myocardial infarction—Bleomycin—melanoma	0.00176	0.00309	CcSEcCtD
Fludarabine—Dysphagia—Carmustine—melanoma	0.00176	0.00309	CcSEcCtD
Fludarabine—Neutropenia—Dactinomycin—melanoma	0.00175	0.00309	CcSEcCtD
Fludarabine—Stomatitis—Bleomycin—melanoma	0.00175	0.00308	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00172	0.00303	CcSEcCtD
Fludarabine—Haematuria—Bleomycin—melanoma	0.00171	0.00301	CcSEcCtD
Fludarabine—Dysphagia—Temozolomide—melanoma	0.0017	0.00299	CcSEcCtD
Fludarabine—Pneumonia—Dactinomycin—melanoma	0.00168	0.00296	CcSEcCtD
Fludarabine—Pancytopenia—Carmustine—melanoma	0.00167	0.00293	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00166	0.00292	CcSEcCtD
Fludarabine—Sweating increased—Temozolomide—melanoma	0.00165	0.00291	CcSEcCtD
Fludarabine—Oesophagitis—Docetaxel—melanoma	0.00164	0.00289	CcSEcCtD
Fludarabine—Neutropenia—Carmustine—melanoma	0.00164	0.00289	CcSEcCtD
Fludarabine—Decreased appetite—Vemurafenib—melanoma	0.00164	0.00289	CcSEcCtD
Fludarabine—Bronchitis—Temozolomide—melanoma	0.00163	0.00287	CcSEcCtD
Fludarabine—Stomatitis—Dactinomycin—melanoma	0.00163	0.00287	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00163	0.00287	CcSEcCtD
Fludarabine—Fatigue—Vemurafenib—melanoma	0.00163	0.00286	CcSEcCtD
Fludarabine—Haemoglobin—Bleomycin—melanoma	0.00162	0.00285	CcSEcCtD
Fludarabine—Constipation—Vemurafenib—melanoma	0.00161	0.00284	CcSEcCtD
Fludarabine—Pancytopenia—Temozolomide—melanoma	0.00161	0.00284	CcSEcCtD
Fludarabine—Haemorrhage—Bleomycin—melanoma	0.00161	0.00283	CcSEcCtD
Fludarabine—Hypoaesthesia—Bleomycin—melanoma	0.0016	0.00282	CcSEcCtD
Fludarabine—Dysuria—Temozolomide—melanoma	0.00159	0.00279	CcSEcCtD
Fludarabine—Neutropenia—Temozolomide—melanoma	0.00159	0.00279	CcSEcCtD
Fludarabine—Hyperglycaemia—Carmustine—melanoma	0.00158	0.00279	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Temozolomide—melanoma	0.00158	0.00278	CcSEcCtD
Fludarabine—Pneumonia—Carmustine—melanoma	0.00157	0.00277	CcSEcCtD
Fludarabine—Renal failure—Carmustine—melanoma	0.00154	0.00271	CcSEcCtD
Fludarabine—SLC29A1—lymph node—melanoma	0.00154	0.0225	CbGeAlD
Fludarabine—Neuropathy peripheral—Carmustine—melanoma	0.00153	0.0027	CcSEcCtD
Fludarabine—Hyperglycaemia—Temozolomide—melanoma	0.00153	0.00269	CcSEcCtD
Fludarabine—Stomatitis—Carmustine—melanoma	0.00153	0.00269	CcSEcCtD
Fludarabine—Urinary tract infection—Carmustine—melanoma	0.00152	0.00268	CcSEcCtD
Fludarabine—Pneumonia—Temozolomide—melanoma	0.00152	0.00268	CcSEcCtD
Fludarabine—Phlebitis—Docetaxel—melanoma	0.00152	0.00267	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.0015	0.00264	CcSEcCtD
Fludarabine—Body temperature increased—Vemurafenib—melanoma	0.00149	0.00263	CcSEcCtD
Fludarabine—Pharyngitis—Dactinomycin—melanoma	0.00149	0.00262	CcSEcCtD
Fludarabine—Neuropathy peripheral—Temozolomide—melanoma	0.00148	0.00261	CcSEcCtD
Fludarabine—Stomatitis—Temozolomide—melanoma	0.00147	0.0026	CcSEcCtD
Fludarabine—Urinary tract infection—Temozolomide—melanoma	0.00147	0.00259	CcSEcCtD
Fludarabine—DCK—lymph node—melanoma	0.00147	0.0215	CbGeAlD
Fludarabine—Deafness—Docetaxel—melanoma	0.00146	0.00257	CcSEcCtD
Fludarabine—Hepatic failure—Docetaxel—melanoma	0.00145	0.00256	CcSEcCtD
Fludarabine—Chills—Bleomycin—melanoma	0.00144	0.00254	CcSEcCtD
Fludarabine—Cardiac failure congestive—Docetaxel—melanoma	0.00144	0.00253	CcSEcCtD
Fludarabine—Alopecia—Bleomycin—melanoma	0.00142	0.0025	CcSEcCtD
Fludarabine—Erythema multiforme—Dactinomycin—melanoma	0.00142	0.0025	CcSEcCtD
Fludarabine—Sinusitis—Temozolomide—melanoma	0.00142	0.0025	CcSEcCtD
Fludarabine—Haemoglobin—Carmustine—melanoma	0.00141	0.00249	CcSEcCtD
Fludarabine—Haemorrhage—Carmustine—melanoma	0.00141	0.00247	CcSEcCtD
Fludarabine—Hypoaesthesia—Carmustine—melanoma	0.0014	0.00246	CcSEcCtD
Fludarabine—Hypersensitivity—Vemurafenib—melanoma	0.00139	0.00245	CcSEcCtD
Fludarabine—Visual disturbance—Docetaxel—melanoma	0.00138	0.00242	CcSEcCtD
Fludarabine—Haemoglobin—Temozolomide—melanoma	0.00136	0.0024	CcSEcCtD
Fludarabine—Haemorrhage—Temozolomide—melanoma	0.00136	0.00239	CcSEcCtD
Fludarabine—Asthenia—Vemurafenib—melanoma	0.00135	0.00238	CcSEcCtD
Fludarabine—Visual impairment—Carmustine—melanoma	0.00135	0.00238	CcSEcCtD
Fludarabine—Hypoaesthesia—Temozolomide—melanoma	0.00135	0.00238	CcSEcCtD
Fludarabine—Pharyngitis—Temozolomide—melanoma	0.00135	0.00237	CcSEcCtD
Fludarabine—Chills—Dactinomycin—melanoma	0.00135	0.00237	CcSEcCtD
Fludarabine—Cardiac failure—Docetaxel—melanoma	0.00134	0.00235	CcSEcCtD
Fludarabine—Pruritus—Vemurafenib—melanoma	0.00134	0.00235	CcSEcCtD
Fludarabine—Alopecia—Dactinomycin—melanoma	0.00133	0.00234	CcSEcCtD
Fludarabine—Visual impairment—Temozolomide—melanoma	0.00131	0.0023	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00131	0.0023	CcSEcCtD
Fludarabine—Ill-defined disorder—Bleomycin—melanoma	0.0013	0.00229	CcSEcCtD
Fludarabine—Anaemia—Bleomycin—melanoma	0.0013	0.00228	CcSEcCtD
Fludarabine—Diarrhoea—Vemurafenib—melanoma	0.00129	0.00227	CcSEcCtD
Fludarabine—Erythema multiforme—Temozolomide—melanoma	0.00128	0.00226	CcSEcCtD
Fludarabine—Malaise—Bleomycin—melanoma	0.00126	0.00222	CcSEcCtD
Fludarabine—Arrhythmia—Carmustine—melanoma	0.00126	0.00221	CcSEcCtD
Fludarabine—Leukopenia—Bleomycin—melanoma	0.00125	0.00221	CcSEcCtD
Fludarabine—Alopecia—Carmustine—melanoma	0.00124	0.00219	CcSEcCtD
Fludarabine—Malnutrition—Carmustine—melanoma	0.00122	0.00215	CcSEcCtD
Fludarabine—Cough—Bleomycin—melanoma	0.00122	0.00215	CcSEcCtD
Fludarabine—Chills—Temozolomide—melanoma	0.00122	0.00214	CcSEcCtD
Fludarabine—Dehydration—Docetaxel—melanoma	0.00121	0.00214	CcSEcCtD
Fludarabine—Ill-defined disorder—Dactinomycin—melanoma	0.00121	0.00213	CcSEcCtD
Fludarabine—Anaemia—Dactinomycin—melanoma	0.00121	0.00213	CcSEcCtD
Fludarabine—Liver function test abnormal—Docetaxel—melanoma	0.00121	0.00212	CcSEcCtD
Fludarabine—Vomiting—Vemurafenib—melanoma	0.0012	0.00211	CcSEcCtD
Fludarabine—Alopecia—Temozolomide—melanoma	0.0012	0.00211	CcSEcCtD
Fludarabine—Myalgia—Bleomycin—melanoma	0.00119	0.0021	CcSEcCtD
Fludarabine—Rash—Vemurafenib—melanoma	0.00119	0.00209	CcSEcCtD
Fludarabine—Dermatitis—Vemurafenib—melanoma	0.00119	0.00209	CcSEcCtD
Fludarabine—Headache—Vemurafenib—melanoma	0.00118	0.00208	CcSEcCtD
Fludarabine—Malnutrition—Temozolomide—melanoma	0.00118	0.00208	CcSEcCtD
Fludarabine—Discomfort—Bleomycin—melanoma	0.00118	0.00207	CcSEcCtD
Fludarabine—Malaise—Dactinomycin—melanoma	0.00118	0.00207	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00118	0.00207	CcSEcCtD
Fludarabine—Leukopenia—Dactinomycin—melanoma	0.00117	0.00206	CcSEcCtD
Fludarabine—Confusional state—Bleomycin—melanoma	0.00115	0.00203	CcSEcCtD
Fludarabine—Oedema—Bleomycin—melanoma	0.00114	0.00201	CcSEcCtD
Fludarabine—Anaphylactic shock—Bleomycin—melanoma	0.00114	0.00201	CcSEcCtD
Fludarabine—Infection—Bleomycin—melanoma	0.00114	0.002	CcSEcCtD
Fludarabine—Anaemia—Carmustine—melanoma	0.00113	0.00199	CcSEcCtD
Fludarabine—Dysphagia—Docetaxel—melanoma	0.00113	0.00199	CcSEcCtD
Fludarabine—Agitation—Carmustine—melanoma	0.00112	0.00198	CcSEcCtD
Fludarabine—Nausea—Vemurafenib—melanoma	0.00112	0.00197	CcSEcCtD
Fludarabine—Thrombocytopenia—Bleomycin—melanoma	0.00112	0.00197	CcSEcCtD
Fludarabine—Myalgia—Dactinomycin—melanoma	0.00111	0.00196	CcSEcCtD
Fludarabine—Discomfort—Dactinomycin—melanoma	0.0011	0.00193	CcSEcCtD
Fludarabine—Angina pectoris—Docetaxel—melanoma	0.0011	0.00193	CcSEcCtD
Fludarabine—Ill-defined disorder—Temozolomide—melanoma	0.0011	0.00193	CcSEcCtD
Fludarabine—Leukopenia—Carmustine—melanoma	0.0011	0.00193	CcSEcCtD
Fludarabine—Anaemia—Temozolomide—melanoma	0.00109	0.00192	CcSEcCtD
Fludarabine—Anorexia—Bleomycin—melanoma	0.00109	0.00192	CcSEcCtD
Fludarabine—Agitation—Temozolomide—melanoma	0.00109	0.00191	CcSEcCtD
Fludarabine—Pancytopenia—Docetaxel—melanoma	0.00107	0.00189	CcSEcCtD
Fludarabine—Oedema—Dactinomycin—melanoma	0.00107	0.00188	CcSEcCtD
Fludarabine—Malaise—Temozolomide—melanoma	0.00107	0.00188	CcSEcCtD
Fludarabine—Convulsion—Carmustine—melanoma	0.00106	0.00187	CcSEcCtD
Fludarabine—Infection—Dactinomycin—melanoma	0.00106	0.00187	CcSEcCtD
Fludarabine—Leukopenia—Temozolomide—melanoma	0.00106	0.00186	CcSEcCtD
Fludarabine—Neutropenia—Docetaxel—melanoma	0.00106	0.00186	CcSEcCtD
Fludarabine—Thrombocytopenia—Dactinomycin—melanoma	0.00104	0.00184	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00104	0.00183	CcSEcCtD
Fludarabine—Myalgia—Carmustine—melanoma	0.00104	0.00183	CcSEcCtD
Fludarabine—Cough—Temozolomide—melanoma	0.00103	0.00182	CcSEcCtD
Fludarabine—Paraesthesia—Bleomycin—melanoma	0.00103	0.00181	CcSEcCtD
Fludarabine—Convulsion—Temozolomide—melanoma	0.00102	0.0018	CcSEcCtD
Fludarabine—Dyspnoea—Bleomycin—melanoma	0.00102	0.00179	CcSEcCtD
Fludarabine—Anorexia—Dactinomycin—melanoma	0.00102	0.00179	CcSEcCtD
Fludarabine—Pneumonia—Docetaxel—melanoma	0.00101	0.00178	CcSEcCtD
Fludarabine—Confusional state—Carmustine—melanoma	0.00101	0.00177	CcSEcCtD
Fludarabine—Arthralgia—Temozolomide—melanoma	0.00101	0.00177	CcSEcCtD
Fludarabine—Myalgia—Temozolomide—melanoma	0.00101	0.00177	CcSEcCtD
Fludarabine—Oedema—Carmustine—melanoma	0.000998	0.00176	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000997	0.00176	CcSEcCtD
Fludarabine—Discomfort—Temozolomide—melanoma	0.000994	0.00175	CcSEcCtD
Fludarabine—Decreased appetite—Bleomycin—melanoma	0.000994	0.00175	CcSEcCtD
Fludarabine—Infection—Carmustine—melanoma	0.000992	0.00175	CcSEcCtD
Fludarabine—Acute coronary syndrome—Docetaxel—melanoma	0.000992	0.00175	CcSEcCtD
Fludarabine—Renal failure—Docetaxel—melanoma	0.000989	0.00174	CcSEcCtD
Fludarabine—Myocardial infarction—Docetaxel—melanoma	0.000986	0.00174	CcSEcCtD
Fludarabine—Neuropathy peripheral—Docetaxel—melanoma	0.000986	0.00174	CcSEcCtD
Fludarabine—Stomatitis—Docetaxel—melanoma	0.000981	0.00173	CcSEcCtD
Fludarabine—Pain—Bleomycin—melanoma	0.000978	0.00172	CcSEcCtD
Fludarabine—Thrombocytopenia—Carmustine—melanoma	0.000978	0.00172	CcSEcCtD
Fludarabine—Confusional state—Temozolomide—melanoma	0.000973	0.00171	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000972	0.00171	CcSEcCtD
Fludarabine—Oedema—Temozolomide—melanoma	0.000965	0.0017	CcSEcCtD
Fludarabine—Anaphylactic shock—Temozolomide—melanoma	0.000965	0.0017	CcSEcCtD
Fludarabine—Infection—Temozolomide—melanoma	0.000959	0.00169	CcSEcCtD
Fludarabine—Anorexia—Carmustine—melanoma	0.000952	0.00167	CcSEcCtD
Fludarabine—Epistaxis—Docetaxel—melanoma	0.000949	0.00167	CcSEcCtD
Fludarabine—Nervous system disorder—Temozolomide—melanoma	0.000946	0.00167	CcSEcCtD
Fludarabine—Thrombocytopenia—Temozolomide—melanoma	0.000945	0.00166	CcSEcCtD
Fludarabine—Feeling abnormal—Bleomycin—melanoma	0.000943	0.00166	CcSEcCtD
Fludarabine—Hyperhidrosis—Temozolomide—melanoma	0.000933	0.00164	CcSEcCtD
Fludarabine—Decreased appetite—Dactinomycin—melanoma	0.000927	0.00163	CcSEcCtD
Fludarabine—Fatigue—Dactinomycin—melanoma	0.00092	0.00162	CcSEcCtD
Fludarabine—Anorexia—Temozolomide—melanoma	0.00092	0.00162	CcSEcCtD
Fludarabine—Pain—Dactinomycin—melanoma	0.000912	0.00161	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Carmustine—melanoma	0.00091	0.0016	CcSEcCtD
Fludarabine—Haemoglobin—Docetaxel—melanoma	0.000908	0.0016	CcSEcCtD
Fludarabine—Body temperature increased—Bleomycin—melanoma	0.000904	0.00159	CcSEcCtD
Fludarabine—Haemorrhage—Docetaxel—melanoma	0.000903	0.00159	CcSEcCtD
Fludarabine—Hypoaesthesia—Docetaxel—melanoma	0.000899	0.00158	CcSEcCtD
Fludarabine—Paraesthesia—Carmustine—melanoma	0.000896	0.00158	CcSEcCtD
Fludarabine—Pharyngitis—Docetaxel—melanoma	0.000896	0.00158	CcSEcCtD
Fludarabine—Dyspnoea—Carmustine—melanoma	0.00089	0.00157	CcSEcCtD
Fludarabine—Feeling abnormal—Dactinomycin—melanoma	0.000879	0.00155	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000879	0.00155	CcSEcCtD
Fludarabine—Visual impairment—Docetaxel—melanoma	0.00087	0.00153	CcSEcCtD
Fludarabine—Decreased appetite—Carmustine—melanoma	0.000868	0.00153	CcSEcCtD
Fludarabine—Paraesthesia—Temozolomide—melanoma	0.000866	0.00152	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Carmustine—melanoma	0.000862	0.00152	CcSEcCtD
Fludarabine—Dyspnoea—Temozolomide—melanoma	0.00086	0.00151	CcSEcCtD
Fludarabine—Erythema multiforme—Docetaxel—melanoma	0.000854	0.0015	CcSEcCtD
Fludarabine—Pain—Carmustine—melanoma	0.000854	0.0015	CcSEcCtD
Fludarabine—Constipation—Carmustine—melanoma	0.000854	0.0015	CcSEcCtD
Fludarabine—Dyspepsia—Temozolomide—melanoma	0.000849	0.00149	CcSEcCtD
Fludarabine—Body temperature increased—Dactinomycin—melanoma	0.000843	0.00148	CcSEcCtD
Fludarabine—Hypersensitivity—Bleomycin—melanoma	0.000843	0.00148	CcSEcCtD
Fludarabine—Decreased appetite—Temozolomide—melanoma	0.000839	0.00148	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Temozolomide—melanoma	0.000833	0.00147	CcSEcCtD
Fludarabine—Fatigue—Temozolomide—melanoma	0.000832	0.00146	CcSEcCtD
Fludarabine—Constipation—Temozolomide—melanoma	0.000825	0.00145	CcSEcCtD
Fludarabine—Pain—Temozolomide—melanoma	0.000825	0.00145	CcSEcCtD
Fludarabine—Feeling abnormal—Carmustine—melanoma	0.000823	0.00145	CcSEcCtD
Fludarabine—Asthenia—Bleomycin—melanoma	0.000821	0.00144	CcSEcCtD
Fludarabine—Chills—Docetaxel—melanoma	0.00081	0.00143	CcSEcCtD
Fludarabine—Pruritus—Bleomycin—melanoma	0.000809	0.00142	CcSEcCtD
Fludarabine—Arrhythmia—Docetaxel—melanoma	0.000807	0.00142	CcSEcCtD
Fludarabine—Alopecia—Docetaxel—melanoma	0.000798	0.0014	CcSEcCtD
Fludarabine—Feeling abnormal—Temozolomide—melanoma	0.000795	0.0014	CcSEcCtD
Fludarabine—Body temperature increased—Carmustine—melanoma	0.000789	0.00139	CcSEcCtD
Fludarabine—Malnutrition—Docetaxel—melanoma	0.000786	0.00138	CcSEcCtD
Fludarabine—Hypersensitivity—Dactinomycin—melanoma	0.000786	0.00138	CcSEcCtD
Fludarabine—Asthenia—Dactinomycin—melanoma	0.000765	0.00135	CcSEcCtD
Fludarabine—Body temperature increased—Temozolomide—melanoma	0.000763	0.00134	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—melanoma	0.000749	0.00212	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PKMYT1—melanoma	0.000745	0.00212	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—INCENP—melanoma	0.000745	0.00212	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UGT2B10—melanoma	0.000745	0.00211	CbGpPWpGaD
Fludarabine—Hypersensitivity—Carmustine—melanoma	0.000736	0.00129	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—CDK2—melanoma	0.000732	0.00208	CbGpPWpGaD
Fludarabine—Diarrhoea—Dactinomycin—melanoma	0.00073	0.00128	CcSEcCtD
Fludarabine—Vomiting—Bleomycin—melanoma	0.000727	0.00128	CcSEcCtD
Fludarabine—Anaemia—Docetaxel—melanoma	0.000727	0.00128	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—PCNA—melanoma	0.000723	0.00205	CbGpPWpGaD
Fludarabine—Rash—Bleomycin—melanoma	0.000721	0.00127	CcSEcCtD
Fludarabine—Dermatitis—Bleomycin—melanoma	0.000721	0.00127	CcSEcCtD
Fludarabine—Asthenia—Carmustine—melanoma	0.000716	0.00126	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000711	0.00202	CbGpPWpGaD
Fludarabine—Hypersensitivity—Temozolomide—melanoma	0.000711	0.00125	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000708	0.00201	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—melanoma	0.000704	0.002	CbGpPWpGaD
Fludarabine—Leukopenia—Docetaxel—melanoma	0.000704	0.00124	CcSEcCtD
Fludarabine—RRM1—Metabolism—HS3ST5—melanoma	0.000692	0.00197	CbGpPWpGaD
Fludarabine—Asthenia—Temozolomide—melanoma	0.000692	0.00122	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000692	0.00197	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000688	0.00195	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDK2—melanoma	0.000687	0.00195	CbGpPWpGaD
Fludarabine—Cough—Docetaxel—melanoma	0.000686	0.00121	CcSEcCtD
Fludarabine—Diarrhoea—Carmustine—melanoma	0.000683	0.0012	CcSEcCtD
Fludarabine—Pruritus—Temozolomide—melanoma	0.000683	0.0012	CcSEcCtD
Fludarabine—Convulsion—Docetaxel—melanoma	0.000681	0.0012	CcSEcCtD
Fludarabine—Nausea—Bleomycin—melanoma	0.000679	0.0012	CcSEcCtD
Fludarabine—Vomiting—Dactinomycin—melanoma	0.000678	0.00119	CcSEcCtD
Fludarabine—Rash—Dactinomycin—melanoma	0.000673	0.00118	CcSEcCtD
Fludarabine—Arthralgia—Docetaxel—melanoma	0.000669	0.00118	CcSEcCtD
Fludarabine—Myalgia—Docetaxel—melanoma	0.000669	0.00118	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000667	0.00189	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—INCENP—melanoma	0.000666	0.00189	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PKMYT1—melanoma	0.000666	0.00189	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDK2—melanoma	0.000661	0.00188	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.00066	0.00187	CbGpPWpGaD
Fludarabine—Diarrhoea—Temozolomide—melanoma	0.00066	0.00116	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000659	0.00187	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—melanoma	0.000658	0.00187	CbGpPWpGaD
Fludarabine—POLA1—S Phase—PCNA—melanoma	0.000656	0.00186	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—melanoma	0.000651	0.00185	CbGpPWpGaD
Fludarabine—Confusional state—Docetaxel—melanoma	0.000647	0.00114	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—E2F1—melanoma	0.000646	0.00183	CbGpPWpGaD
Fludarabine—Oedema—Docetaxel—melanoma	0.000642	0.00113	CcSEcCtD
Fludarabine—Anaphylactic shock—Docetaxel—melanoma	0.000642	0.00113	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000639	0.00181	CbGpPWpGaD
Fludarabine—Infection—Docetaxel—melanoma	0.000637	0.00112	CcSEcCtD
Fludarabine—Vomiting—Carmustine—melanoma	0.000635	0.00112	CcSEcCtD
Fludarabine—Nausea—Dactinomycin—melanoma	0.000634	0.00112	CcSEcCtD
Fludarabine—Rash—Carmustine—melanoma	0.000629	0.00111	CcSEcCtD
Fludarabine—Nervous system disorder—Docetaxel—melanoma	0.000629	0.00111	CcSEcCtD
Fludarabine—Dermatitis—Carmustine—melanoma	0.000629	0.00111	CcSEcCtD
Fludarabine—Thrombocytopenia—Docetaxel—melanoma	0.000628	0.00111	CcSEcCtD
Fludarabine—DCK—Metabolism—ACER3—melanoma	0.000627	0.00178	CbGpPWpGaD
Fludarabine—Headache—Carmustine—melanoma	0.000625	0.0011	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000621	0.00176	CbGpPWpGaD
Fludarabine—Vomiting—Temozolomide—melanoma	0.000613	0.00108	CcSEcCtD
Fludarabine—Anorexia—Docetaxel—melanoma	0.000612	0.00108	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000611	0.00173	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—PCNA—melanoma	0.000609	0.00173	CbGpPWpGaD
Fludarabine—Rash—Temozolomide—melanoma	0.000608	0.00107	CcSEcCtD
Fludarabine—Dermatitis—Temozolomide—melanoma	0.000608	0.00107	CcSEcCtD
Fludarabine—Headache—Temozolomide—melanoma	0.000604	0.00106	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—RB1—melanoma	0.000602	0.00171	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDK2—melanoma	0.0006	0.0017	CbGpPWpGaD
Fludarabine—Nausea—Carmustine—melanoma	0.000593	0.00104	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000591	0.00168	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00059	0.00168	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000585	0.00103	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN1B—melanoma	0.000583	0.00166	CbGpPWpGaD
Fludarabine—Paraesthesia—Docetaxel—melanoma	0.000576	0.00101	CcSEcCtD
Fludarabine—DCK—Metabolism—UGT2B10—melanoma	0.000573	0.00163	CbGpPWpGaD
Fludarabine—Nausea—Temozolomide—melanoma	0.000573	0.00101	CcSEcCtD
Fludarabine—Dyspnoea—Docetaxel—melanoma	0.000572	0.00101	CcSEcCtD
Fludarabine—POLA1—S Phase—CDK4—melanoma	0.000567	0.00161	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000565	0.0016	CbGpPWpGaD
Fludarabine—Dyspepsia—Docetaxel—melanoma	0.000565	0.000994	CcSEcCtD
Fludarabine—POLA1—DNA Replication—RB1—melanoma	0.000564	0.0016	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000561	0.00159	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—POT1—melanoma	0.000561	0.00159	CbGpPWpGaD
Fludarabine—Decreased appetite—Docetaxel—melanoma	0.000558	0.000982	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDK2—melanoma	0.000557	0.00158	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—melanoma	0.000555	0.00158	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—ALB—melanoma	0.000555	0.00157	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Docetaxel—melanoma	0.000554	0.000975	CcSEcCtD
Fludarabine—Fatigue—Docetaxel—melanoma	0.000553	0.000974	CcSEcCtD
Fludarabine—Pain—Docetaxel—melanoma	0.000549	0.000966	CcSEcCtD
Fludarabine—Constipation—Docetaxel—melanoma	0.000549	0.000966	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—RB1—melanoma	0.000543	0.00154	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN1A—melanoma	0.000538	0.00153	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000533	0.00151	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000533	0.00151	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HS3ST5—melanoma	0.000533	0.00151	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.00053	0.0015	CbGpPWpGaD
Fludarabine—Feeling abnormal—Docetaxel—melanoma	0.000529	0.000931	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDK4—melanoma	0.000527	0.0015	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000525	0.00149	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLCB4—melanoma	0.000525	0.00149	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000521	0.00148	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000518	0.00147	CbGpPWpGaD
Fludarabine—Body temperature increased—Docetaxel—melanoma	0.000507	0.000893	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—melanoma	0.000507	0.00144	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000506	0.00144	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.0005	0.00142	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC6A11—melanoma	0.000493	0.0014	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIP4K2A—melanoma	0.000493	0.0014	CbGpPWpGaD
Fludarabine—POLA1—S Phase—RB1—melanoma	0.000493	0.0014	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000489	0.00139	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000484	0.00138	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—melanoma	0.000483	0.00137	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTAP—melanoma	0.00048	0.00136	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00048	0.00136	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.00048	0.00136	CbGpPWpGaD
Fludarabine—Hypersensitivity—Docetaxel—melanoma	0.000473	0.000832	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00047	0.00134	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00047	0.00133	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1B—melanoma	0.000468	0.00133	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—melanoma	0.000468	0.00133	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000462	0.00131	CbGpPWpGaD
Fludarabine—Asthenia—Docetaxel—melanoma	0.00046	0.00081	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RB1—melanoma	0.000458	0.0013	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000457	0.0013	CbGpPWpGaD
Fludarabine—Pruritus—Docetaxel—melanoma	0.000454	0.000799	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000453	0.00129	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000453	0.00129	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000451	0.00128	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—melanoma	0.000446	0.00127	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000445	0.00126	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000443	0.00126	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000442	0.00125	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000441	0.00125	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000439	0.00125	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDKN1B—melanoma	0.000439	0.00125	CbGpPWpGaD
Fludarabine—Diarrhoea—Docetaxel—melanoma	0.000439	0.000773	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000435	0.00123	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—melanoma	0.000432	0.00123	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PHGDH—melanoma	0.000428	0.00121	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LUM—melanoma	0.000428	0.00121	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1B—melanoma	0.000423	0.0012	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000422	0.0012	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HPSE—melanoma	0.00042	0.00119	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—melanoma	0.000414	0.00117	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CUBN—melanoma	0.000412	0.00117	CbGpPWpGaD
Fludarabine—Vomiting—Docetaxel—melanoma	0.000408	0.000718	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1A—melanoma	0.000405	0.00115	CbGpPWpGaD
Fludarabine—Rash—Docetaxel—melanoma	0.000405	0.000712	CcSEcCtD
Fludarabine—Dermatitis—Docetaxel—melanoma	0.000404	0.000711	CcSEcCtD
Fludarabine—DCK—Metabolism—PLCB4—melanoma	0.000404	0.00115	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ABCB1—melanoma	0.000403	0.036	CrCbGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—melanoma	0.000403	0.00114	CbGpPWpGaD
Fludarabine—Headache—Docetaxel—melanoma	0.000402	0.000707	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000401	0.00114	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000399	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000399	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SDHD—melanoma	0.000398	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—BSG—melanoma	0.000398	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CSPG4—melanoma	0.000398	0.00113	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1A—melanoma	0.00039	0.00111	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—melanoma	0.000388	0.0011	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GPAM—melanoma	0.000385	0.00109	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1B—melanoma	0.000384	0.00109	CbGpPWpGaD
Fludarabine—Nausea—Docetaxel—melanoma	0.000381	0.000671	CcSEcCtD
Fludarabine—DCK—Metabolism—PIP4K2A—melanoma	0.00038	0.00108	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC6A11—melanoma	0.00038	0.00108	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000377	0.00107	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—SKP2—melanoma	0.000376	0.00107	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000376	0.00107	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000371	0.00105	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTAP—melanoma	0.000369	0.00105	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000367	0.00104	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—melanoma	0.000366	0.00104	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000359	0.00102	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000359	0.00102	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000357	0.00101	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1A—melanoma	0.000354	0.00101	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00035	0.000993	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000344	0.000976	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—AURKA—melanoma	0.000344	0.000976	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000342	0.00097	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—melanoma	0.00034	0.000966	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MLH1—melanoma	0.00034	0.000965	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000339	0.000963	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—SKP2—melanoma	0.000336	0.000954	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000336	0.000954	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000332	0.000944	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LUM—melanoma	0.000329	0.000935	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PHGDH—melanoma	0.000329	0.000935	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000329	0.000934	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLA2G6—melanoma	0.000327	0.00093	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—MYC—melanoma	0.000324	0.000919	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HPSE—melanoma	0.000323	0.000916	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000318	0.000904	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CUBN—melanoma	0.000317	0.0009	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—E2F1—melanoma	0.000317	0.000899	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000316	0.000898	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000311	0.000884	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PRKCA—melanoma	0.00031	0.000881	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—AURKA—melanoma	0.000307	0.000872	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CSPG4—melanoma	0.000306	0.000869	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SDHD—melanoma	0.000306	0.000869	CbGpPWpGaD
Fludarabine—DCK—Metabolism—BSG—melanoma	0.000306	0.000869	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000301	0.000855	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.0003	0.000852	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—APEX1—melanoma	0.000299	0.000847	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPAM—melanoma	0.000296	0.000841	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000296	0.00084	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—VCAN—melanoma	0.000294	0.000835	CbGpPWpGaD
Fludarabine—POLA1—S Phase—MYC—melanoma	0.000294	0.000834	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000292	0.000828	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000285	0.00081	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—melanoma	0.000282	0.0008	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—CDK2—melanoma	0.000273	0.000776	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—melanoma	0.000273	0.000774	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.00027	0.000767	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—APEX1—melanoma	0.000267	0.000758	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000265	0.000752	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000258	0.000733	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000258	0.000731	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000255	0.000724	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000254	0.000722	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLA2G6—melanoma	0.000252	0.000715	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000249	0.000708	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000249	0.000706	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP17A1—melanoma	0.000248	0.000705	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000248	0.000703	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—E2F1—melanoma	0.000237	0.000673	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GNA11—melanoma	0.000234	0.000665	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PRKCA—melanoma	0.000232	0.000659	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2B—melanoma	0.000231	0.000655	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—FASN—melanoma	0.000229	0.000651	CbGpPWpGaD
Fludarabine—DCK—Metabolism—VCAN—melanoma	0.000226	0.000643	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC5A5—melanoma	0.000226	0.000641	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000225	0.000638	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RB1—melanoma	0.000225	0.000638	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PCNA—melanoma	0.000223	0.000634	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GNAQ—melanoma	0.000218	0.000619	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CD44—melanoma	0.000218	0.000619	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000212	0.000603	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—E2F1—melanoma	0.000212	0.000601	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—melanoma	0.00021	0.000597	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP1B1—melanoma	0.000209	0.000593	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PRKCA—melanoma	0.000208	0.000589	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000207	0.000587	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK2—melanoma	0.000204	0.00058	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000202	0.000574	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000202	0.000574	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PCNA—melanoma	0.0002	0.000567	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK4—melanoma	0.000193	0.000548	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TERT—melanoma	0.000193	0.000548	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000193	0.000547	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP17A1—melanoma	0.000191	0.000542	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000191	0.000542	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK2—melanoma	0.000183	0.000519	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GNA11—melanoma	0.00018	0.000512	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FASN—melanoma	0.000177	0.000501	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000175	0.000498	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC5A5—melanoma	0.000174	0.000493	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—ATM—melanoma	0.000173	0.000492	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK4—melanoma	0.000173	0.00049	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCB1—melanoma	0.000172	0.000488	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00017	0.000482	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RB1—melanoma	0.000168	0.000477	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GNAQ—melanoma	0.000168	0.000476	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CD44—melanoma	0.000168	0.000476	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1B1—melanoma	0.000161	0.000456	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PRKCA—melanoma	0.000158	0.000449	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ERCC2—melanoma	0.000157	0.000446	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—RB1—melanoma	0.00015	0.000426	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—melanoma	0.000148	0.000419	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000143	0.000407	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—melanoma	0.000138	0.00039	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCB1—melanoma	0.000132	0.000376	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—melanoma	0.000132	0.000375	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—melanoma	0.000131	0.000372	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—melanoma	0.000131	0.000371	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MDM2—melanoma	0.000128	0.000364	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—melanoma	0.000125	0.000354	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CG—melanoma	0.000124	0.000352	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PRKCA—melanoma	0.000122	0.000346	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ERCC2—melanoma	0.000121	0.000343	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—melanoma	0.000121	0.000343	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—melanoma	0.00012	0.00034	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1B—melanoma	0.000117	0.000332	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—melanoma	0.000112	0.000317	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CD—melanoma	0.000109	0.000309	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1A—melanoma	0.000108	0.000306	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—melanoma	0.000108	0.000306	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK3—melanoma	0.000103	0.000292	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—melanoma	0.0001	0.000284	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK1—melanoma	9.79e-05	0.000278	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—melanoma	9.54e-05	0.000271	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CB—melanoma	9.5e-05	0.00027	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—melanoma	9.42e-05	0.000267	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—melanoma	9.21e-05	0.000261	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK3—melanoma	9.2e-05	0.000261	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—melanoma	8.95e-05	0.000254	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK1—melanoma	8.75e-05	0.000248	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CD—melanoma	8.39e-05	0.000238	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—melanoma	8.28e-05	0.000235	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—melanoma	8.21e-05	0.000233	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—melanoma	7.35e-05	0.000209	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CB—melanoma	7.31e-05	0.000208	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—melanoma	7.25e-05	0.000206	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—melanoma	6.32e-05	0.000179	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—melanoma	5.79e-05	0.000164	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—melanoma	4.73e-05	0.000134	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—melanoma	4.46e-05	0.000127	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—melanoma	3.64e-05	0.000103	CbGpPWpGaD
